Data coverage, completeness and provenance for ALTERITY THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:10:11. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.2650 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.2600 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.2400 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.2400 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.2650 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/ATH/prices · Price parameters and adjustment semantics
Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
Employees: 11 · Website: https://alteritytherapeutics.com · Profile fields populated: 75%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/ATH/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 25 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 25 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 26 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 26 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 5 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/ATH
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/ATH/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/ATH/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/ATH/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/ATH/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ATH
Free tier — instant API key. Built for AI agents.